Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
63
ENSC Quote, Financials, Valuation and Earnings
Last price:
$8.15
Seasonality move
:
-16.27%
Day range:
$7.49 - $8.59
52-week range:
$2.12 - $30.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.52x
Volume:
154.8K
Avg. volume:
222.2K
1-year change:
-51.77%
Market cap:
$10.5M
Revenue:
--
EPS (TTM):
-$31.05
Earnings Data
Next earnings date for ENSC
Mar 21
2025
Most recent earnings per share
$1.05
Beat by $1.05
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ENSC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/21/2025 | Q4 | $245K | -- | -- | -$1.95 | -- |
| 11/12/2024 | Q3 | $200K | -- | $1.05 | -- | -- |
| 08/14/2024 | Q2 | $300K | -- | -$3.30 | -$5.25 | $1.95 |
| 05/13/2024 | Q1 | $400K | -- | -$8.25 | -$11.25 | $3.00 |
| 03/21/2024 | Q4 | $490K | -- | -$20.55 | -- | -- |
| 11/09/2023 | Q3 | $593.3K | -- | -$13.05 | -- | -- |
| 06/30/2023 | Q2 | $826.7K | -- | -$14.70 | -$80.25 | $65.55 |
| 05/17/2023 | Q1 | $950K | -- | -$31.20 | -$87.60 | $56.40 |
| 12/31/2022 | Q4 | $1.5M | -- | -$273.60 | -$367.20 | $93.60 |
| 09/30/2022 | Q3 | -- | -- | -$923.70 | -- | -- |
| 08/16/2022 | Q2 | -- | -- | -$847.35 | -- | -- |
| 05/17/2022 | Q1 | -- | -- | -$219.90 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$1,620.00 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$2,547.00 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$138.74 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$134.62 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $31.74 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | $232.91 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$104.48 | -- | -- |
Ensysce Biosciences Earnings Questions
-
How Much did Ensysce Biosciences Generate in Revenue Last Quarter?
Ensysce Biosciences reported -- worth of top line sales in its most recent quarter.
-
Did Ensysce Biosciences Beat Earnings Last Quarter?
Ensysce Biosciences announced earnings per share of $1.05 which represents a beat of analyst forecast a -- per share.
-
Is Ensysce Biosciences Profitable?
Ensysce Biosciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Ensysce Biosciences EPS Next Year?
Ensysce Biosciences's earnings are forecast to decrease from -$70.35 per share to -- per share next year representing a decrease of -82.3%.
-
When is Ensysce Biosciences's Earnings Date?
Ensysce Biosciences's next earnings date is March 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
